Ballal Rahul D. Insider Trades

Insider Trading History

Track insider trading activity for Ballal Rahul D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $608k 17,126 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 17,126 shares
$27.16
$35.49
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.8k 2,302 shares
$35.08
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $357k 12,414 shares
Last Trade
Aug 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$80.8k 2,302 shares
$35.08
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $291k 10,112 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $454k 15,768 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 15,768 shares
$35.50
$28.79
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $727k 20,491 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 20,491 shares
$22.47
$35.49
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $518k 17,992 shares
Last Trade
Nov 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$591k 10,000 shares
$59.06
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $517k 17,947 shares
Last Trade
Nov 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$591k 10,000 shares
$59.06
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $415k 14,421 shares
Last Trade
Nov 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$582k 10,000 shares
$58.19
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $284k 9,860 shares
Last Trade
Nov 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$535k 10,000 shares
$53.52
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $805k 27,947 shares
Last Trade
Nov 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$551k 10,000 shares
$55.08
$28.79
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.16M 32,761 shares
Last Trade
Oct 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$292k 10,420 shares
$28.01
$35.49
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $793k 22,341 shares
Last Trade
Oct 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$294k 10,420 shares
$28.17
$35.49
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $2.46M 69,428 shares
Last Trade
Oct 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$292k 10,420 shares
$28.01
$35.49
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $230k 7,992 shares
Last Trade
Aug 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 2,302 shares
$43.70
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $66.3k 2,302 shares
Last Trade
Aug 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 2,302 shares
$43.70
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $339k 11,774 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 11,774 shares
$42.45
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $164k 5,690 shares
Last Trade
Jun 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$28.79
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$28.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up